Skip to Content

Dominari Holdings Inc DOMH

Morningstar Rating
$1.92 +0.03 (1.59%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DOMH is trading at a 778% premium.
Price
$1.88
Fair Value
$7.71
Uncertainty
Extreme
1-Star Price
$13.72
5-Star Price
$3.34
Economic Moat
Dwzh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DOMH is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.89
Day Range
$1.862.00
52-Week Range
$1.763.40
Bid/Ask
$1.87 / $1.92
Market Cap
$11.40 Mil
Volume/Avg
11,944 / 9,502

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.05
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
28

Valuation

Metric
DOMH
Price/Earnings (Normalized)
Price/Book Value
0.24
Price/Sales
3.05
Price/Cash Flow
Price/Earnings
DOMH

Financial Strength

Metric
DOMH
Quick Ratio
5.66
Current Ratio
15.89
Interest Coverage
Quick Ratio
DOMH

Profitability

Metric
DOMH
Return on Assets (Normalized)
−24.23%
Return on Equity (Normalized)
−26.33%
Return on Invested Capital (Normalized)
−26.03%
Return on Assets
DOMH
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
JnvhjlwbhXjvbm$636.2 Bil
Vertex Pharmaceuticals Inc
VRTX
LclpycjnnNjtylq$126.1 Bil
Regeneron Pharmaceuticals Inc
REGN
XzmydrvhRpcpxj$121.2 Bil
Moderna Inc
MRNA
CscrzrxmCykz$46.5 Bil
Alnylam Pharmaceuticals Inc
ALNY
DcwmwzjLjwsvx$33.0 Bil
argenx SE ADR
ARGX
XbnljbbbkQfbpg$27.9 Bil
BioNTech SE ADR
BNTX
LnplggvlcKylw$20.5 Bil
Biomarin Pharmaceutical Inc
BMRN
XrbchdthpJdcsk$16.1 Bil
United Therapeutics Corp
UTHR
YnxnmvdgTywj$14.3 Bil
Incyte Corp
INCY
ZrnbtjpJnwchkm$12.5 Bil

Sponsor Center